2008
DOI: 10.1016/j.cbi.2008.03.017
|View full text |Cite
|
Sign up to set email alerts
|

In vitro effect of gliclazide on DNA damage and repair in patients with type 2 diabetes mellitus (T2DM)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
20
0
2

Year Published

2010
2010
2022
2022

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 52 publications
(24 citation statements)
references
References 46 publications
2
20
0
2
Order By: Relevance
“…Previous studies have utilised the Comet assay to investigate oxidative damage in relation to various conditions including diabetes [28] and obesity, where an association between DNA damage, BMI, antioxidant status and MDA concentration was observed [29]. Our study showed a significant difference in Comet intensity, head intensity and tail intensity in the ODM group compared to O group.…”
Section: Discussionsupporting
confidence: 53%
“…Previous studies have utilised the Comet assay to investigate oxidative damage in relation to various conditions including diabetes [28] and obesity, where an association between DNA damage, BMI, antioxidant status and MDA concentration was observed [29]. Our study showed a significant difference in Comet intensity, head intensity and tail intensity in the ODM group compared to O group.…”
Section: Discussionsupporting
confidence: 53%
“…It has been suggested that it decreases hyperglycemia and hyperinsulinemia and inhibits oxidative stress. It is also a promising therapeutic candidate for the prevention of vascular complications of diabetes, by decreasing the level of DNA damage induced by reactive oxygen species [13, 40]. Also it has been found that gliclazide reduced oxidative stress in liver and kidney tissues of diabetic rats [11, 41].…”
Section: Discussionmentioning
confidence: 99%
“…These agents are reported to benefit the diabetic patients in reducing both hyperglycemia and also the mutagenic complications associated with enhanced oxidative stress. [27][28][29][30] In this study, following 4 weeks of insulin (regular) treatment to NA-STZ diabetic animals, although reduction in the elevated blood glucose was observed [ Figure 1], the incidences of MN frequency and sperm abnormalities as well as the diminished antioxidant status was not altered [Tables 1-3]. These observations indicated that the tested doses of insulin did not protect the bone marrow erythrocytes and spermatozoa cells against the reactive oxygen species induced lesion in diabetic condition.…”
Section: Discussionmentioning
confidence: 99%